A new HIV vaccine has generated powerful broadly neutralizing antibodies in animal studies and has now entered human trials, ...

Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully ...

LJI Instructor Dr. Patrick Madden said the team wants to see antibody response in 100% of the animals, not just 44%.

Add Yahoo as a preferred source to see more of our stories on Google. Lenacapavir is now approved to prevent HIV infection as well as to treat certain infections. - Gilead Sciences Inc. A drug ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies ...

As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention, RFI spoke with infectious disease specialist Ndong Essomba Bitchoka about ...

Vaccinating against HIV has been a decades-long effort, stymied by the virus’s high mutation rate and mask of human glycans.

After decades of failed HIV vaccines, a new approach that predicts which cells to train, not just what antigen to show, has ...

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the ...

The last person I expected to catch me off guard that summer’s evening was my 52-year-old aunt. We were roasting fresh maize ...

Witkoppen Clinic says the long-acting Lenacapavir injection gives eligible patients a convenient alternative to daily HIV ...

Around 44% of rhesus macaques vaccinated with the new HIV vaccine produced broadly neutralizing antibodies against HIV. The ...